366 related articles for article (PubMed ID: 33148545)
1. Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017.
Wang L; Ze F; Li J; Mi L; Han B; Niu H; Zhao N
Heart; 2021 Jun; 107(11):881-887. PubMed ID: 33148545
[TBL] [Abstract][Full Text] [Related]
2. Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2019.
Dong XJ; Wang BB; Hou FF; Jiao Y; Li HW; Lv SP; Li FH
Europace; 2023 Mar; 25(3):793-803. PubMed ID: 36603845
[TBL] [Abstract][Full Text] [Related]
3. Global, regional, and national burden of disease study of atrial fibrillation/flutter, 1990-2019: results from a global burden of disease study, 2019.
Li H; Song X; Liang Y; Bai X; Liu-Huo WS; Tang C; Chen W; Zhao L
BMC Public Health; 2022 Nov; 22(1):2015. PubMed ID: 36329400
[TBL] [Abstract][Full Text] [Related]
4. Global burden of atrial fibrillation/flutter due to high systolic blood pressure from 1990 to 2019: estimates from the global burden of disease study 2019.
Jin Y; Wang K; Xiao B; Wang M; Gao X; Zhang J; Lu J
J Clin Hypertens (Greenwich); 2022 Nov; 24(11):1461-1472. PubMed ID: 36210736
[TBL] [Abstract][Full Text] [Related]
5. Global, regional, and national burdens of atrial fibrillation/flutter from 1990 to 2019: An age-period-cohort analysis using the Global Burden of Disease 2019 study.
Li X; Liu Z; Jiang X; Xia R; Li Y; Pan X; Yao Y; Fan X
J Glob Health; 2023 Nov; 13():04154. PubMed ID: 37988383
[TBL] [Abstract][Full Text] [Related]
6. Global burden of atrial fibrillation/flutter: Trends from 1990 to 2019 and projections until 2044.
Ma Q; Zhu J; Zheng P; Zhang J; Xia X; Zhao Y; Cheng Q; Zhang N
Heliyon; 2024 Jan; 10(2):e24052. PubMed ID: 38293361
[TBL] [Abstract][Full Text] [Related]
7. Global Burden of Atrial Fibrillation and Flutter by National Income: Results From the Global Burden of Disease 2019 Database.
Ohlrogge AH; Brederecke J; Schnabel RB
J Am Heart Assoc; 2023 Sep; 12(17):e030438. PubMed ID: 37646216
[TBL] [Abstract][Full Text] [Related]
8. Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 2019.
Jiang X; Ling J; Xiong Q; Chen W; Zou L; Ling Z
Eur Heart J Qual Care Clin Outcomes; 2024 May; ():. PubMed ID: 38710536
[TBL] [Abstract][Full Text] [Related]
9. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
Chugh SS; Havmoeller R; Narayanan K; Singh D; Rienstra M; Benjamin EJ; Gillum RF; Kim YH; McAnulty JH; Zheng ZJ; Forouzanfar MH; Naghavi M; Mensah GA; Ezzati M; Murray CJ
Circulation; 2014 Feb; 129(8):837-47. PubMed ID: 24345399
[TBL] [Abstract][Full Text] [Related]
10. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
GBD 2017 Oesophageal Cancer Collaborators
Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
[TBL] [Abstract][Full Text] [Related]
11. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015.
GBD 2015 Tobacco Collaborators
Lancet; 2017 May; 389(10082):1885-1906. PubMed ID: 28390697
[TBL] [Abstract][Full Text] [Related]
12. Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017.
Dai H; Zhang Q; Much AA; Maor E; Segev A; Beinart R; Adawi S; Lu Y; Bragazzi NL; Wu J
Eur Heart J Qual Care Clin Outcomes; 2021 Oct; 7(6):574-582. PubMed ID: 32735316
[TBL] [Abstract][Full Text] [Related]
13. Estimates of the global, regional, and national burden of atrial fibrillation in older adults from 1990 to 2019: insights from the Global Burden of Disease study 2019.
Jiao M; Liu C; Liu Y; Wang Y; Gao Q; Ma A
Front Public Health; 2023; 11():1137230. PubMed ID: 37377555
[TBL] [Abstract][Full Text] [Related]
14. Increasing prevalence of atrial fibrillation and flutter in the United States.
Naccarelli GV; Varker H; Lin J; Schulman KL
Am J Cardiol; 2009 Dec; 104(11):1534-9. PubMed ID: 19932788
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter.
Ahmari SA; Bunch TJ; Chandra A; Chandra V; Ujino K; Daly RC; Kushwaha SS; Edwards BS; Maalouf YF; Seward JB; McGregor CG; Chandrasekaran K
J Heart Lung Transplant; 2006 Jan; 25(1):53-60. PubMed ID: 16399531
[TBL] [Abstract][Full Text] [Related]
16. Global, regional, and national cancer deaths and disability-adjusted life-years (DALYs) attributable to alcohol consumption in 204 countries and territories, 1990-2019.
Safiri S; Nejadghaderi SA; Karamzad N; Carson-Chahhoud K; Bragazzi NL; Sullman MJM; Almasi-Hashiani A; Mansournia MA; Collins GS; Kaufman JS; Kolahi AA
Cancer; 2022 May; 128(9):1840-1852. PubMed ID: 35239973
[TBL] [Abstract][Full Text] [Related]
17. Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.
Dasari TW; Pavlovic-Surjancev B; Patel N; Williams AA; Ezidinma P; Rupani A; Sinacore JL; Heroux AL
Am J Cardiol; 2010 Sep; 106(5):737-41. PubMed ID: 20723655
[TBL] [Abstract][Full Text] [Related]
18. Incremental cost burden to US healthcare payers of atrial fibrillation/atrial flutter patients with additional risk factors.
Amin AN; Jhaveri M; Lin J
Adv Ther; 2011 Oct; 28(10):907-26. PubMed ID: 21971681
[TBL] [Abstract][Full Text] [Related]
19. Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis.
Romero J; Diaz JC; Di Biase L; Kumar S; Briceno D; Tedrow UB; Valencia CR; Baldinger SH; Koplan B; Epstein LM; John R; Michaud GF; Stevenson WG
J Interv Card Electrophysiol; 2017 Apr; 48(3):307-315. PubMed ID: 28070875
[TBL] [Abstract][Full Text] [Related]
20. Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).
Haywood LJ; Ford CE; Crow RS; Davis BR; Massie BM; Einhorn PT; Williard A;
J Am Coll Cardiol; 2009 Nov; 54(22):2023-31. PubMed ID: 19926008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
